Results 201 to 210 of about 96,425 (243)

Catalytic Strategies For the Synthesis of Dehydrozingerone: Structural Features and Emerging Applications—A Critical Review

ChemCatChem, Volume 18, Issue 1, 15 January 2026.
This review emphasizes the main methods for synthesizing dehydrozingerone (DHZ), highlighting the aldol condensation reaction of vanillin with acetone using homogeneous and heterogeneous catalysts. Furthermore, the main pharmacological properties that characterize DHZ are presented, along with current challenges and perspectives in its production ...
Paula Ramirez, José J. Martinez, Gustavo Romanelli, Maria H. Brijaldo, Fabio B. Passos   +4 more
wiley   +1 more source

Circ-PAN3 facilitates hepatocellular carcinoma growth via sponging miR-153 and upregulating cyclin D1. [PDF]

Oncol Res
Yu S, Wang M, Li XU, Guo X, Qin R.
europepmc   +1 more source

BRCA1 overexpression sensitizes cancer cells to lovastatin via regulation of cyclin D1-CDK4-p21WAF1/CIP1 pathway: analyses using a breast cancer cell line and tumoral xenograft model

, 1992
Fujun Yu
openalex   +2 more sources

Practical implications of the World Health Organization Reporting System for Lymph Node, Spleen, and Thymus Cytopathology: Categories and ancillary testing for subtyping of hematolymphoid tumors on FNA biopsy cytopathology using a pattern‐based approach

Cancer Cytopathology, Volume 134, Issue 1, January 2026.
Abstract The objective of the recently published World Health Organization Reporting System for Lymph Node, Spleen, and Thymus Cytopathology (WHO system) is to standardize the diagnostic approach to fine‐needle aspiration biopsies of hematolymphoid tissues.
Mats Ehinger, Maria Calaminici, Immacolata Cozzolino, Pio Zeppa, Andrew S. Field   +4 more
wiley   +1 more source

Pan‐cancer multi‐omics reveals DCAF7 as an immune‐modulating prognostic driver and Wnt/β‐catenin activator in hepatocellular carcinoma

Clinical and Translational Medicine, Volume 16, Issue 1, January 2026.
DCAF7 is up‐regulated in various tumours and correlates with poor prognosis, particularly in LIHC. High DCAF7 expression is linked to CD4+ T cell infiltration, up‐regulation of immune checkpoint genes and increased tumour mutational burden, suggesting a role in tumour immune escape.
Ruina Luan, Hanbin Lin, Xin Zhao, Jianpeng Li, Maohe Chen, Shiping Luo, Xinjian Lin   +6 more
wiley   +1 more source

MiR 329/449 Suppresses Cell Proliferation, Migration and Synergistically Sensitizes GBM to TMZ by Inhibiting Src/FAK, NF-kB, and Cyclin D1 Activity. [PDF]

Int J Mol Sci
Mendieta M, Bandegi M, Biltekin E, Akay YM, Ozpolat B, Akay M.   +5 more
europepmc   +1 more source

High Expression of Cyclin D1 and p21 in N-Nitroso-N-Methylurea-Induced Breast Cancer in Wistar Albino Female Rats.

, 2012
Mahboobeh Ashrafi, S. Zahra Bathaie, Saeid Abroun   +2 more
openalex   +1 more source

Synthetic lethality in cancer therapy: Mechanisms, models and clinical translation for overcoming therapeutic resistance

Clinical and Translational Medicine, Volume 16, Issue 1, January 2026.
Application of synthetic lethality screening in drug resistance models. Abstract Background and Rationale Synthetic lethality (SL)‐based strategies hold significant promise for overcoming therapeutic resistance, a critical bottleneck in cancer treatment where cancer cells evade anticancer therapies, leading to diminished efficacy or treatment failure ...
Junyan Li, Liyuan Zhang, Yan Shang, Juan Liu, Hailong Zhao   +4 more
wiley   +1 more source

Expression of Cyclin D1 and Claudin-1 in Invasive Breast Carcinoma and Their Correlation with Clinicopathological Parameters. [PDF]

Iran J Pathol
Sehrawat R, Dhawan V, Roy M, Kediya A, Nijhawan VS.   +4 more
europepmc   +1 more source

Growth Inhibition of Head and Neck Squamous Cell Carcinoma Cells by sgRNA Targeting the Cyclin D1 mRNA Based on TRUE Gene Silencing

, 2014
Satoshi Iizuka, Nobuhiko Oridate, Masayuki Nashimoto, Satoshi Fukuda, Masato Tamura   +4 more
openalex   +2 more sources